// App-Quantinova.ai

P5-15-07 : Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]

Researchers

Presenter

  • Gajra A

Principal Investigators

  • McCall L

  • Muss HB

  • Hurria ACohen HJJatoi A

  • Ballman KV

  • Partridge AH

  • Sutton L

  • Parker BA

  • Magrinat G

  • Lafky JM

Medical Centers

  • City of Hope Comprehensive Cancer Center, Monrovia, CA

  • Upstate Medical University, Syracuse, NYDuke University Medical Center, Durham, NCDana-Farber Cancer Institute, Boston, MA

  • University of North Carolina, Chapel Hill, NC

  • Cone Health Cancer Center, Greensboro, NC

  • UC San Diego Moores Cancer Cancer, La Jolla, CA

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Depression

  • Anxiety

  • Solid malignancies

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved